EP2476697 - Bibliographic data

Vaccins de peptide pour cancers exprimant les polypeptides MPHOSPH1

Last update	01/06/2025
Legal status	Brevet déchu
Origin	Européen

(73) Holder	Oncotherapy Science, Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 Japon
(72) Inventors	Tomoaki Fujioka Department of Urology Iwate Medical University School of Medicine 19-1 Uchimaru Morioka-shi Iwate 020-8505 Japon Yusuke Nakamura The University of Tokyo 3-1, Hongo 7-chome Bunkyo-ku Tokyo 113-8654 Japon Takuya Tsunoda The University of Tokyo 3-1, Hongo 7-chome Bunkyo-ku Tokyo 113-8654 Japon Ryuji Osawa Oncotherapy Science, Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 Japon Midori Shida Oncotherapy Science, Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 Japon
(74) Agent	Mail recipient Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München Allemagne

(21) Request number	EP12155444.8
(22) Request date	16/10/2007

(11) Publication number	EP2476697
Publication date	17/06/2015

(54) Title of the invention	Vaccins de peptide pour cancers exprimant les polypeptides MPHOSPH1
(51) International classification	C07K 14/47, A61K 38/00, A61K 39/00, A61P 35/00, C07K 7/06, C12N 15/09, C12N 9/14
International classification (before reform)	None

Claimed priority	(31) Number: 852575 P (32) Date: 17/10/2006 (33) Country: US
Initial application	None
Divisional application	None

Expected annuity	Annuity: 9 - Amount: 120 € - Due date 03/11/2015 Surtax: 9 - Amount: 24 € - Due date 04/05/2016
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2015/35, of 28/08/2015
History	Publication de la délivrance du brevet européen - Legal date 17/06/2015 Entrée en période de grâce du brevet d'invention - Legal date 04/11/2015 Déchéance du brevet d'invention après période de grâce - Legal date 03/11/2015